NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog

Go back to NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog
NEOGENOMICS (NASDAQ: NEO) Delayed: 17.38 --0 (-0%)
Previous Close $17.38    52 Week High $9.54 
Open $17.38    52 Week Low $5.49 
Day High $17.38    P/E 434.50 
Day Low $17.38    EPS $0.04 
Volume 2,549